Using PICO Methodology to Answer Questions About Smoking in COPD Patients
Arch Bronconeumol. 2017 Nov;53(11):622-628.
doi: 10.1016/j.arbres.2017.04.012.
Epub 2017 May 27.
[Article in
English,
Spanish]
Authors
Carlos A Jiménez Ruiz
1
, Daniel Buljubasich
2
, Juan Antonio Riesco Miranda
3
, Agustín Acuña Izcaray
4
, José Ignacio de Granda Orive
5
, José Miguel Chatkin
6
, Gustavo Zabert
7
, Alfredo Guerreros Benavides
8
, Nelson Paez Espinel
9
, Valeri Noé
10
, Efraín Sánchez-Angarita
11
, Ingrid Núñez-Sánchez
12
, Raúl H Sansores
10
, Alejandro Casas
13
, Andrés Palomar Lever
14
, Inmaculada Alfageme Michavila
15
Affiliations
- 1 Unidad Especializada en Tabaquismo, PII Tabaquismo SEPAR, Madrid, España. Electronic address: victorina@ctv.es.
- 2 Servicio de Neumología, Hospital Español, Grupo Tabaquismo ALAT Rosario, Argentina.
- 3 Servicio de Neumología, Hospital San Pedro de Alcántara, Cáceres, España.
- 4 Hospital Universitario de Caracas, Universidad Central de Venezuela. Centro Médico Docente La Trinidad, Caracas, Venezuela.
- 5 Servicio de Neumología, Hospital Universitario 12 de Octubre. Área de Tabaquismo SEPAR, Madrid, España.
- 6 Medicina Interna, Faculdade de Medicina, Pontificia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brasil.
- 7 Asociación Latinoamericana del Tórax, Facultad de Ciencias Médicas, Universidad Nacional del Comahue, Neuquén, Argentina.
- 8 Facultad de Medicina San Fernando, Universidad Nacional Mayor de San Marcos. Sociedad Peruana de Neumología, Lima, Perú.
- 9 Fundación Neumológica Colombiana. Programa de cesación de Tabaquismo «Exfumaire». Universidad de La Sabana, Chía, Colombia.
- 10 Departamento de Investigación en Tabaquismo y EPOC, Instituto Nacional de Enfermedades Respiratorias, Ciudad de México, México.
- 11 Servicio de Neumología, Hospital Universitario de Caracas, Universidad Central de Venezuela, Centro Médico docente La Trinidad, Caracas, Venezuela.
- 12 Servicio de Neumología y Cirugía de Tórax, Hospital Universitario de Caracas, Universidad Central de Venezuela, Caracas, Venezuela.
- 13 Universidad del Rosario, Fundación Neumológica Colombiana, Bogotá, Colombia.
- 14 Centro médico ABC de la Ciudad de México, Escuela de Medicina del TEC de Monterrey Campus ABC de la Ciudad México, Ciudad de México, México.
- 15 Hospital Universitario Virgen de Valme, Universidad de Sevilla. SEPAR, Sevilla, España.
Abstract
The ALAT and SEPAR Treatment and Control of Smoking Groups have collaborated in the preparation of this document which attempts to answer, by way of PICO methodology, different questions on health interventions for helping COPD patients to stop smoking. The main recommendations are: (i)moderate-quality evidence and strong recommendation for performing spirometry in COPD patients and in smokers with a high risk of developing the disease, as a motivational tool (particularly for showing evidence of lung age), a diagnostic tool, and for active case-finding; (ii)high-quality evidence and strong recommendation for using intensive dedicated behavioral counselling and drug treatment for helping COPD patients to stop smoking; (iii)high-quality evidence and strong recommendation for initiating interventions for helping COPD patients to stop smoking during hospitalization with improvement when the intervention is prolonged after discharge, and (iv)high-quality evidence and strong recommendation for funding treatment of smoking in COPD patients, in view of the impact on health and health economics.
Keywords:
Chronic obstructive pulmonary disease; Enfermedad pulmonar obstructiva crónica; Espirometría; Smoking; Spirometry; Tabaquismo; Tratamiento; Treatment.
Copyright © 2017 SEPAR. Publicado por Elsevier España, S.L.U. All rights reserved.
MeSH terms
-
Biomarkers
-
Bupropion / economics
-
Bupropion / therapeutic use
-
Clinical Trials as Topic
-
Cost-Benefit Analysis
-
Counseling / economics
-
Counseling / methods
-
Evidence-Based Medicine / methods*
-
Humans
-
Motivation
-
Nicotine / economics
-
Nicotine / therapeutic use
-
Nicotinic Agonists / economics
-
Nicotinic Agonists / therapeutic use
-
Pulmonary Disease, Chronic Obstructive / physiopathology
-
Pulmonary Disease, Chronic Obstructive / psychology*
-
Randomized Controlled Trials as Topic
-
Smoking / drug therapy
-
Smoking / economics
-
Smoking / psychology*
-
Smoking / therapy
-
Smoking Cessation / economics
-
Smoking Cessation / methods
-
Smoking Cessation / psychology*
-
Spirometry / psychology*
-
Surveys and Questionnaires
-
Varenicline / economics
-
Varenicline / therapeutic use
Substances
-
Biomarkers
-
Nicotinic Agonists
-
Bupropion
-
Nicotine
-
Varenicline